Furthermore, Zhan et al. demonstrated that LOXL2 promoted the esophageal squamous cell carcinoma (ESCC) metastasis by inducing ezrin phosphorylation-mediated cytoskeletal reorganization53. Here, LOXL2 is linked to esophageal squamous cell carcinoma.